Akzo Nobel N.V. AKZOF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.01B | 2.79B | 2.76B | 2.98B | 2.98B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.01B | 2.79B | 2.76B | 2.98B | 2.98B |
| Cost of Revenue | 1.72B | 1.60B | 1.67B | 1.78B | 1.73B |
| Gross Profit | 1.29B | 1.19B | 1.09B | 1.20B | 1.25B |
| SG&A Expenses | 959.54M | 931.33M | 615.81M | 906.06M | 928.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.33M | -3.51M | -324.78M | 319.17M | -2.27M |
| Total Operating Expenses | 2.69B | 2.53B | 2.28B | 3.00B | 2.66B |
| Operating Income | 324.50M | 259.74M | 479.61M | -24.55M | 324.59M |
| Income Before Tax | 251.23M | 173.16M | 868.42M | -112.23M | 203.15M |
| Income Tax Expenses | 77.93M | 54.99M | 162.97M | 109.90M | 49.94M |
| Earnings from Continuing Operations | 173.30M | 118.17M | 705.44M | -222.13M | 153.22M |
| Earnings from Discontinued Operations | -1.16M | -- | 0.00 | -1.17M | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -10.47M | -9.36M | -9.31M | -3.51M | -12.48M |
| Net Income | 161.67M | 108.81M | 696.13M | -226.81M | 140.73M |
| EBIT | 324.50M | 259.74M | 479.61M | -24.55M | 324.59M |
| EBITDA | 431.50M | 368.55M | 593.69M | 85.35M | 429.00M |
| EPS Basic | 0.94 | 0.64 | 4.07 | -1.33 | 0.82 |
| Normalized Basic EPS | 0.94 | 0.74 | 1.41 | -0.30 | 0.94 |
| EPS Diluted | 0.94 | 0.63 | 4.06 | -1.33 | 0.82 |
| Normalized Diluted EPS | 0.94 | 0.73 | 1.40 | -0.30 | 0.93 |
| Average Basic Shares Outstanding | 171.40M | 171.20M | 171.10M | 171.00M | 171.00M |
| Average Diluted Shares Outstanding | 171.60M | 172.22M | 171.84M | 171.00M | 172.22M |
| Dividend Per Share | -- | -- | 1.79 | 0.00 | 0.50 |
| Payout Ratio | 193.53% | 3.23% | 6.19% | -13.92% | 216.94% |